TQL-1055 |CAS 2095876-40-5|DC Chemicals

Cas No.:	2095876-40-5
Chemical Name:	Olean-12-en-28-oic acid, 3,16-dihydroxy-23-oxo-, O-β-D-xylopyranosyl-(1→4)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-4-[(11-carboxy-1-oxoundecyl)amino]-4-deoxy-β-D-galactopyranosyl ester, (3β,4α,16α)-
Synonyms:	Olean-12-en-28-oic acid, 3,16-dihydroxy-23-oxo-, O-β-D-xylopyranosyl-(1→4)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-4-[(11-carboxy-1-oxoundecyl)amino]-4-deoxy-β-D-galactopyranosyl ester, (3β,4α,16α)-;2095876-40-5;TQL-1055;Olean-12-en-28-oic acid, 3,16-dihydroxy-23-oxo-, O-beta-D-xylopyranosyl-(1-->4)-O-6-deoxy-alpha-L-mannopyranosyl-(1-->2)-4-[(11-carboxy-1-oxoundecyl)amino]-4-deoxy-beta-D-galactopyranosyl ester, (3beta,4alpha,16alpha)-;O-beta-D-Xylopyranosyl-(1-->4)-O-6-deoxy-alpha-L-mannopyranosyl-(1-->2)-4-[(11-carboxy-1-oxoundecyl)amino]-4-deoxy-beta-D-galactopyranosyl (3beta,4alpha,16alpha)-3,16-dihydroxy-23-oxoolean-12-en-28-oate;S3V4K4WP47
SMILES:	O[C@H]1[C@@]2(C(=O)O[C@H]3[C@@H]([C@H]([C@H]([C@@H](CO)O3)NC(CCCCCCCCCCC(=O)O)=O)O)O[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O)CCC(C)(C)C[C@H]2C2=CC[C@@H]3[C@@]4(C)CC[C@@H]([C@](C=O)(C)[C@@H]4CC[C@@]3(C)[C@]2(C)C1)O
Formula:	C₅₉H₉₅NO₂₀
M.Wt:	1138.38
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

Cat. No.	Product name	Field of application
DC67240	KRN-7000(7DW8-5)
DC67239	KRN-7000(S34)
DC67238	KRN-7000(C34)
DC67237	TQL-1055	TQL-1055 is a semi-synthetic analog of the saponin adjuvant QS-21 (HY-101092) and can be used as a prophylactic vaccine adjuvant. TQL-1055 exhibits robust adjuvant activity for influenza antigens. TQL-1055 combined with the acellular pertussis vaccine (aP) shows good tolerance and enhances the antibody response to pertussis toxin (PT) in mice and rabbits. TQL-1055 is promising for research of chronic hepatitis B.
DC67236	QS-7	QS 7 (QS 7 Api) is a saponin compound that can be extracted from the Quillaja saponaria tree. QS 7 activates immune cells, enhances their antigen presentation ability and cytokine secretion. QS 7 can be used as vaccine adjuvant for immunostimulating, anti-tumor, and anti-infectious activities.
DC67235	CPG 7909
DC67233	AYK004-C1	AYK004-C1 is a TLR agonist. AYK004-C1 can be used to prepare immune adjuvants.
DC67232	AYK004-B1	AYK004-B1 is a TLR7 agonist (EC50=0.2265 nM). AYK004-B1 can be used to prepare immune adjuvants.
DC67231	AYK004	AYK004 is a TLR7/8 agonist that enhances immune responses by activating the TLR signaling pathway. AYK004 is an adenine derivative with a favorable hydrophilic-lipophilic balance, which improves the loading capacity and stability in immunoadjuvant systems such as liposomes, while reducing the side effects of the immunoadjuvant system in systemic immunity .
DC67230	AYK005	AYK005 is a TLR7/8 immunologic adjuvant.